1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. Fosun International Limited
  6. News
  7. Summary
    656   HK0656038673

FOSUN INTERNATIONAL LIMITED

(656)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Fosun International : Hospital da Luz Lisboa with Maximum Rating of Clinical Excellence

01/12/2022 | 09:31pm EDT
Hospital da Luz Lisboa with Maximum Rating of Clinical Excellence
Release Time:2022-01-12Author:Source: Pageviews:

The evaluation by the Health Regulatory Authority assigned Hospital da Luz Lisboa the maximum of stars in clinical excellence.

January 10, 2022 - Hospital da Luz Lisboa is the hospital in the country with the largest number of clinical areas classified with the maximum rating of excellence, according to the latest evaluation performed by the national Health Regulatory Authority (ERS), in the context of the SINAS program (National System of Evaluation in Health). The HLL obtained maximum rating in six out of the ten clinical areas submitted to the evaluation of the regulating authority in the sector (a number only equalled by Hospital de Braga).

SINAS is an evaluation system of global quality in healthcare providing establishments, with volunteer participation. This report refers to the period between the 1st July 2018 and the 30th June 2019.

The maximum rating (three stars) is assigned when the results are higher to the average of the totality of healthcare providers englobed in the evaluation (156). The Hospital da Luz Lisboa obtained such rating in the following areas:

· General Surgery (Colon Surgery);

· Vascular Surgery (Arterial Revascularization Surgery);

· Intensive Care (Intensive Care Unit);

· Gynaecology (Hysterectomy);

· Neurology (Cerebral Vascular Accident - Stroke);

· Orthopaedics (Total Hip and Knee Arthroplasty).

Furthermore, the HLL obtained a high rating (two stars) in other four clinical areas:

· Cardiology (Acute Myocardial Infarction - AMI);

· Cardiac Surgery (Myocardial Revascularization Surgery);

· Cardiac Surgery (Heart Valve Surgery and other Non-coronary Cardiac Surgery);

· Orthopaedics (Proximal Femur Fractures).

Maximum ratings for the 11th consecutive year

This was the 11th consecutive year that Hospital da Luz Lisboa was evaluated by ERS in the context of SINAS program. Also in previous years, the hospital obtained the maximum ratings of clinical excellence in these major areas of healthcare providing.

These results confirm the strong investment of Hospital da Luz Lisboa in quality medicine and reinforce the value of the largest private hospital of Luz Saúde group, as a healthcare provider of reference.

Other units of Hospital da Luz network with high or maximum ratings

Four other units of Hospital da Luz network also submitted themselves to the ERS evaluation and all obtained the maximum rating of clinical excellence in the area of Orthopaedics (Total Hip and Knee Arthroplasty) - namely Hospital da Luz Arrábida, Hospital da Luz Aveiro, Hospital da Luz Póvoa de Varzim and Hospital da Luz Setúbal.

Hospital da Luz Arrábida (in Vila Nova de Gaia) also obtained the maximum rating in Gynaecology (Hysterectomy) and high ratings in other four clinical areas: Orthopaedics (Proximal Femur Fractures), Delivery and Prenatal Care, Colon Surgery, Myocardial Revascularization Surgery and Heart Valve Surgery, and other Non-coronary Cardiac Surgery).

Previous:Already the First ArticleNext:Fosun International's MSCI ESG rating upgraded to AA

Disclaimer

Fosun International Limited published this content on 12 January 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 13 January 2022 02:30:06 UTC.


© Publicnow 2022
All news about FOSUN INTERNATIONAL LIMITED
05/23Robot++ announced that it has received $15 million in funding from Meituan, Fosun Inter..
CI
05/23RobotPlusPlus announced that it has received $15 million in funding from Meituan, Fosun..
CI
05/05Metaverse, web3 and football club valuations
AQ
04/29FOSUN INTERNATIONAL : 2021 ESG Report Highlights in a Glance
PU
04/28Fosun International to Vote June 2 on New Share Issuance, Buyback Plans
MT
04/27FOSUN INTERNATIONAL : CSR Report 2021
PU
04/27FOSUN INTERNATIONAL : Sustain Resilience and Develop Business for Good to Empower the Futu..
PU
04/25FOSUN INTERNATIONAL : World Malaria Day | Fosun Pharma's Self-Developed Artemisinin Series..
PU
04/19XU XIAOLIANG, CO-CEO OF FOSUN INTERN : Fosun, a Synonym for Happiness
PU
04/14CHEN QIYU, CO-CEO OF FOSUN INTERNATI : Fosun's ESG Journey to a Happier Life
PU
More news
Analyst Recommendations on FOSUN INTERNATIONAL LIMITED
More recommendations
Financials
Sales 2022 174 B 25 871 M 25 871 M
Net income 2022 12 758 M 1 893 M 1 893 M
Net Debt 2022 135 B 20 084 M 20 084 M
P/E ratio 2022 4,29x
Yield 2022 5,05%
Capitalization 54 514 M 8 090 M 8 090 M
EV / Sales 2022 1,09x
EV / Sales 2023 1,04x
Nbr of Employees 96 000
Free-Float 27,1%
Chart FOSUN INTERNATIONAL LIMITED
Duration : Period :
Fosun International Limited Technical Analysis Chart | 656 | HK0656038673 | MarketScreener
Technical analysis trends FOSUN INTERNATIONAL LIMITED
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 9
Last Close Price 6,56 CNY
Average target price 9,30 CNY
Spread / Average Target 41,8%
EPS Revisions
Managers and Directors
Qi Yu Chen Co-Chief Executive Officer & Executive Director
Xiao Liang Xu Co-Chief Executive Officer & Executive Director
Ping Gong Chief Financial Officer & Executive Director
Hou Lin Zhang Co-Chief Financial Officer & Senior Vice President
Li Gang Zhang Co-CFO & GM-Financial Management
Sector and Competitors
1st jan.Capi. (M$)
FOSUN INTERNATIONAL LIMITED-9.16%8 090
CHUBB LIMITED7.44%88 482
ALLIANZ SE-4.26%86 554
MARSH & MCLENNAN COMPANIES-12.27%78 970
ZURICH INSURANCE GROUP LTD10.31%68 161
BAJAJ FINSERV LIMITED-24.38%25 571